RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.
RareCyte has raised $20.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.
RareCyte's investors include Arboretum Ventures, 5AM Ventures, Agilent Technologies, HealthQuest Capital, The Forest Road Company.
RareCyte is headquartered in Seattle, United States.
RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.
RareCyte is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RareCyte — Funding & Investors." VCBacked, June 27, 2024, https://www.vcbacked.co/company/rarecyte. Accessed September 30, 2026.
VCBacked. (2024). RareCyte — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/rarecyte
{{cite web |title=RareCyte — Funding & Investors |url=https://www.vcbacked.co/company/rarecyte |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated